Background {#Sec1}
==========

*Corynebacterium pseudotuberculosis* is a Gram-positive facultative intracellular pathogen of the Corynebacterium, Mycobacterium, Nocardia, and Rhodococcus (CMNR) group. The CMNR group of pathogens has high G + C content in their genomes and shows a specific cell wall organization composed of peptidoglycan, arabinogalactan, and mycolic acids \[[@CR1]\]. *C. pseudotuberculosis* is subdivided into two biovars: (i) *C. pseudotuberculosis* biovar *ovis* (nitrate negative) which is the etiologic agent of caseous lymphadenitis in small ruminants \[[@CR2]\] and mastitis in dairy cattle \[[@CR3]\] and (ii) *C. pseudotuberculosis* biovar *equi* (nitrate positive) that causes ulcerative lymphangitis and abscesses in internal organs of equines \[[@CR4]\] and oedematous skin disease in buffalos \[[@CR5]\]. *C. pseudotuberculosis* infection is reported worldwide and causes significant economic losses by affecting wool, meat, and milk production \[[@CR6]--[@CR9]\].

Various studies at genome level have been carried out by our research group in order to explore the molecular basis of specific and shared factors among different strains of *C. pseudotuberculosis* that could contribute to such biovar specific pathogenicity. Our studies on whole-genome sequencing and analysis of several *C. pseudotuberculosis* strains belonging to biovar *ovis* and *equi*, isolated from different hosts showed an average genome size of approximately 2,3 Mb, a core-genome having approximately 1504 genes across several *C. pseudotuberculosis* species, and accessory genomes of biovar *equi* and *ovis* composed of 95 and 314 genes, respectively \[[@CR10]--[@CR12]\]. According with pan-genome analysis, *C. pseudotuberculosis* biovar *ovis* presented a more clonal-like behavior, than the *C. pseudotuberculosis* biovar *equi.* In addition, in this *in silico* study was observed a variability most interesting related to pilus genes, where biovar *ovis* strain presented high similarity, while, biovar *equi* strains have a great variability, suggesting that this variability could influence in the adhesion and invasion cellular of each biovar \[[@CR10]\].

Apart from the structural genome informatics studies of *C. pseudotuberculosis*, some proteomic studies were conducted to explore the functional genome of this pathogen \[[@CR13]--[@CR19]\]. However, all these proteomic studies were performed using only strains belonging to biovar *ovis*. Until the present time, no proteomic studies were performed between biovar *equi* strains or between biovar *ovis* and biovar *equi* strains. Therefore, to provide insights on shared and exclusive proteins among biovar *ovis* and biovar *equi* strains and to complement the previous studies on functional and structural genomics of *C. pseudotuberculosis* biovars, using LC-MS^E^ approach \[[@CR13], [@CR18]\] this study reports for the first time a comparative proteomic analysis of two *C. pseudotuberculosis* strains, 1002\_*ovis* and 258\_*equi*, isolated from caprine (Brazil) and equine (Belgium), respectively. Our proteomic dataset promoted the validations of previous work*in silico* of *C. pseudotuberculosis*; in addition, the qualitative and quantitative differences in the proteins identified in this present work have potential to help understand the factors that might contribute for pathogenic process of biovar *ovis* and *equi* strains.

Methods {#Sec2}
=======

Bacterial strain and growth condition {#Sec3}
-------------------------------------

*C. pseudotuberculosis* biovar *ovis* 1002, isolated from a goat in Brazil, and *C. pseudotuberculosis* biovar *equi* 258, isolated from a horse in Belgium, were maintained in brain--heart infusion broth or agar (1.5%) (BHI-HiMedia Laboratories Pvt. Ltd., India) at 37 °C. For proteomic analysis, overnight cultures (three biological replicate to each strain) in BHI were inoculated with a 1:100 dilution in fresh BHI at 37 °C and cells were harvested during the exponential growth at DO~600~ = 0.8 (Additional file [1](#MOESM1){ref-type="media"}: Figure S1).

Protein extraction and preparation of whole bacterial lysates for LC-MS/MS {#Sec4}
--------------------------------------------------------------------------

After bacterial growth, the protein extraction was performed according to Silva et al. \[[@CR18]\]. The cultures were centrifuged at 4000 x g at 4 °C for 20 min. The cell pellets were washed in phosphate buffered saline (PBS) and then resuspended in 1 mL of lysis buffer (7 M Urea, 2 M Thiourea, CHAPS 4% and 1 M DTT) and 10 μL of Protease Inhibitor Mix (GE Healthcare, Piscataway, NJ, USA) was added. The cells were broken by sonication at 5 × 1 min cycles on ice and the lysates were centrifuged at 14,000 x g for 30 min at 4 °C. Subsequently, samples were concentrated and lysis buffer was replaced by 50 mM ammonium bicarbonate at pH 8.0 using a 10 kDa ultra-filtration device (Millipore, Ireland). All centrifugation steps were performed at room temperature. Finally the protein concentration was determined by Bradford method \[[@CR20]\]. A total of 50 μg proteins from each biological replicate of 1002\_*ovis* and 258\_*equi* were denatured by using RapiGEST SF \[(0.1%) (Waters, Milford, CA, USA)\] at 60 °C for 15 min, reduced with DTT \[(10 mM) (GE Healthcare)\], and alkylated with iodoacetamide \[(10 mM) (GE Healthcare)\]. For enzymatic digestion, trypsin \[(0.5 μg/μL) (Promega, Sequencing Grade Modified Trypsin, Madison, WI, USA)\] was added and placed in a thermomixer at 37 °C overnight. The digestion process was stopped by the addition of 10 μL of 5% TFA (Sigma-Aldrich, St. Louis, Missouri, USA) and glycogen phosphorilase (Sigma-Aldrich) was added to the digests to give 20 fmol.uL^−1^ as an internal standard for scouting normalization prior to each replicate injection into label-free quantitation \[[@CR21]\].

LC-HDMS^E^ analysis and data processing {#Sec5}
---------------------------------------

Qualitative and quantitative analysis were performed using 2D RPxRP (two-dimensional reversed phase) nanoUPLC-MS (Nano Ultra Performance Liquid Chromatography Mass Spectrometry) approach with multiplexed Nano Electrospray High Definition Mass Spectrometry (nanoESI-HDMS^E^). To ensure that all samples were injected with the same amount into the columns and to ensure standardized molar values across all conditions, stoichiometric measurements based on scouting runs of the integrated total ion account (TIC) were performed prior to analysis. The experiments were conducted using both a 1 h reversed phase gradient from 7% to 40% (*v*/v) acetonitrile (0.1% *v*/v formic acid) and a 500 nL.min^−1^ on a 2D nanoACQUITY UPLC technology system \[[@CR22]\]. A nanoACQUITY UPLC HSS (High Strength Silica) T3 1.8 μm, 75 μm × 15 cm column (pH 3) was used in conjunction with a reverse phase (RP) XBridge BEH130 C18 5 μm 300 μm × 50 mm nanoflow column (pH 10). Typical on-column sample loads were 250 ng of total protein digests for each 5 fractions (250 ng/fraction/load). For all measurements, the mass spectrometer was operated in the resolution mode with a typical m/z resolving power of at least 35,000 FMHW and an ion mobility cell filled with nitrogen gas and a cross-section resolving power at least 40 Ω/ΔΩ. All analyses were performed using nano-electrospray ionization in the positive ion mode nanoESI (+) and a NanoLockSpray (Waters, Manchester, UK) ionization source.

The lock mass channel was sampled every 30 s. The mass spectrometer was calibrated with a MS/MS spectrum of \[Glu1\]-Fibrinopeptide B human (Glu-Fib) solution (100 fmol.uL^−1^) delivered through the reference sprayer of the NanoLockSpray source.The doubly- charged ion (\[M + 2H\]^2+^ = 785.8426) was used for initial single-point calibration and MS/MS fragment ions of Glu-Fib were used to obtain the final instrument calibration. Multiplexed data-independent (DIA) scanning with added specificity and selectivity of a non-linear 'T-wave' ion mobility (HDMS^E^) experiments were performed with a Synapt G2-S HDMS mass spectrometer (Waters), which was automatically planned to switch between standard MS (3 eV) and elevated collision energies HDMS^E^ (19--45 eV) applied to the transfer 'T-wave' CID (collision-induced dissociation) cell with argon gas. The trap collision cell was adjusted for 1 eV, using a mili-seconds scan time previously adjusted based on the linear velocity of the chromatography peak delivered through nanoACQUITY UPLC to get a minimum of 20 scan points for each single peak, both in low energy and at high-energy transmission at an orthogonal acceleration time-of-flight (oa-TOF) from m/z 50 to 2000. The RF offset (MS profile) was adjusted is such a way that the nanoUPLC-HDMS^E^ data are effectively acquired from m/z 400 to 2000, which ensured that any masses observed in the high energy spectra with less than m/z 400 arise from dissociations in the collision cell.

Database searching and quantification {#Sec6}
-------------------------------------

Following the identification of proteins, the quantitative data were packaged using dedicated algorithms \[[@CR23], [@CR24]\] and searching against a database with default parameters to account for ions \[[@CR25]\]. The databases used were reversed "on-the fly" during the database queries and appended to the original database to assess the false positive rate (FDR) during identification. For proper spectra processing and database searching conditions, the Protein Lynx Global Server v.2.5.2 (PLGS) with Identity^E^ and Expression^E^ informatics v.2.5.2 (Waters) were used. UniProtKB (release 2013_01) with manually reviewed annotations was used, and the search conditions were based on taxonomy (*Corynebacterium pseudotuberculosis*). We have utilized a database from genome annotation of 1002\_*ovis* CP001809.2 version and 258\_*equi* CP003540.2 version. These databases were randomized within PLGS v.2.5.2 for generate a concatenated database from both genomes. Thus, the measured MS/MS spectra from proteomic datasets of 1002\_*ovis* and 258\_*equi* were searched against this concatenated database. The maximum allowed missed cleavages by trypsin were up to one, and variable modifications by carbamidomethyl (C), acetyl N-terminal, phosphoryl (STY) and oxidation (M) were allowed and peptide mass tolerance value of 10 ppm was used \[[@CR26]\]. Peptides as source fragments, peptides with a charge state of at least \[M + 2H\]^2+^ and the absence of decoys were the factors we considered to increase the data quality. The collected proteins were organized by the PLGS Expression^E^ tool algorithm into a statistically significant list that corresponded to higher or lower regulation ratios among the different groups. For protein quantitation, the PLGS v2.5.2 software was used with the IdentityE algorithm using the Hi3 methodology. The search threshold to accept each spectrum was the default value in the program with a false discovery rate value of 4%. The quantitative values were averaged over all samples, and the standard deviations at *p* \< 0.05 were determined using the Expression software. Only proteins with a differential expression log2 ratio between the two conditions greater than or equal to 1.2 were considered \[[@CR26]\].

Bioinformatics analysis {#Sec7}
-----------------------

The identified proteins in 1002\_*ovis* and 258\_*equi* were subjected to the bioinformatics analysis using the various prediction tools. SurfG+ v1.0 \[[@CR27]\] was used to predict sub-cellular localization, SignalP 4.1.0 server \[[@CR28]\] to predict the presence of N-terminal signal peptides for secretory proteins, SecretomeP 2.0 server \[[@CR29]\] to identify exported proteins from non-classical systems (positive prediction score greater than to 0.5), LipoP server \[[@CR30]\] to determine lipoproteins, Blast2GO \[[@CR31]\] and COG database \[[@CR32]\] were used for functional annotations. The protein-protein interaction network was generated using Cytoscape version 2.8.3 \[[@CR33]\] with a spring-embedded layout.

Results and discussion {#Sec8}
======================

Characterization of the proteome of *C. pseudotuberculosis* biovar *ovis* and *equi* {#Sec9}
------------------------------------------------------------------------------------

In this study, we applied the 2D nanoUPLC-HDMS^E^ approach to characterize the proteome of the strains 1002\_*ovis* and 258\_*equi*. Both strains were grown in BHI media, subsequently proteins were extracted and digested in solution, and then the peptides were analyzed by LC/MS^E^. Our proteomic analysis identified a total of 1227 non-redundant proteins in 1002\_*ovis* (Additional file [2](#MOESM2){ref-type="media"}: Table S1 and Additional file [3](#MOESM3){ref-type="media"}: Table S2) and 1218 in 258\_*equi* (Additional file [2](#MOESM2){ref-type="media"}: Table S1 and Additional file [4](#MOESM4){ref-type="media"}: Table S3) (Fig. [1a](#Fig1){ref-type="fig"}). The information about sequence coverage and a number of identified peptides for each protein sequence identified, as well as the information about the native peptide are available at Additional file [5](#MOESM5){ref-type="media"}: Table S4 and Additional file [6](#MOESM6){ref-type="media"}: Table S5. Altogether from the proteome of these two biovars, we identified a total of 1323 different proteins of *C. pseudotuberculosis* with high confidence (Fig. [1a](#Fig1){ref-type="fig"}) and characterized approximately 58% of the predicted proteome of 1002\_*ovis* \[[@CR11]\] (Fig. [1b](#Fig1){ref-type="fig"}). In the case of 258\_*equi*, we characterized approximately 57% of the predicted proteome \[[@CR12]\] (Fig. [1b](#Fig1){ref-type="fig"}). The proteins identified in both proteomes were analyzed by SurfG+ tool \[[@CR27]\] to predict the subcellular localization into four categories: cytoplasmic (CYT), membrane (MEM), potentially surface-exposed (PSE) and secreted (SEC) (Fig. [1c](#Fig1){ref-type="fig"}). Further, we identified 83% (43 proteins) of the lipoproteins predicted in 1002\_*ovis* and 79% (41 proteins) in 258\_*equi*. Considering proteins with LPxTG motif which are involved in covalent linkage with peptidoglycan, we identified 6 proteins in 1002\_*ovis* and 4 proteins in 258\_*equi* that correspond to approximately 38% and 34% of the LPxTG proteins predicted in each strain, respectively.Fig. 1Characterization of the proteome of *C. pseudotuberculosis* and correlation with *in silico* data. **a** Distribution of the proteins identified in the proteome of 1002\_*ovis* and 258\_*equi*, represented by Venn diagram. **b** Correlation of the proteomic results with *in silico* data of the genomes of 1002\_*ovis* and 258\_*equi*. **c** Subcellular localization of the identified proteins and correlation with the *in silico* predicted proteome. CYT, cytoplasmic; MEM, membrane; PSE, potentially surface-exposed and SEC, secreted

The biovar *equi* and biovar *ovis* core proteome {#Sec10}
-------------------------------------------------

The core-proteome, between 258\_*equi* and 1002\_*ovis* is composed of 1122 proteins (Fig. [1](#Fig1){ref-type="fig"}) (Additional file [2](#MOESM2){ref-type="media"}: Table S1). Interestingly, when correlated these 1122 proteins with in silico data of the *C. pseudotuberculosis* core-genome \[[@CR10]\], we observed that 86% (960 proteins) of the *Open Reading Frame* (ORF) that encodes these proteins are part of the core-genome (Additional file [2](#MOESM2){ref-type="media"}: Table S1), what represents approximately 64% of the predicted core-genome of this pathogen. In addition, these data show a set of proteins involved in different cellular processes which could be necessary for the free living of *C. pseudotuberculosis*. The other 14% (262 proteins) of the proteins that constitute the core-proteome are shared by at least one of the 15 strains used in the core-genome study. According to Gene Ontology analysis \[[@CR31], [@CR32]\], the 1122 proteins were classified into four important functional groups: (i) metabolism, (ii) information storage and processing, (iii) cellular processes and signaling, and (iv) poorly characterized (Fig. [2a](#Fig2){ref-type="fig"}). As observed in the study of *C. pseudotuberculosis* \[[@CR10]\] core genome in the categories "metabolism" and "information storage and processing" were detected a large number of proteins.Fig. 2Representative results of the core-proteome 1002\_*ovis* and 258\_*equi*. **a** Functional distribution of the proteins identified in the core-proteome. **b** Volcano plot generated by differentially expressed proteins, log2 ratio of 258\_*equi/*1002\_*ovis*. **c** Biological processes differential between 258\_*equi* and 1002\_*ovis*

The label-free quantification was applied to evaluate the relative abundance of the core-proteome of 258\_*equi* and 1002\_*ovis*. The ProteinLynx Global Server (PLGS) v2.5.2 software with Expression^E^ algorithm tool was used to identify proteins with *p* ≤ 0.05 (Additional file [2](#MOESM2){ref-type="media"}: Table S1). Among these proteins, 120 proteins between 258\_*equi* and 1002\_*ovis* showed difference in level of abundance (log~2~ ratios equal or greater than a factor of 1.2) \[[@CR26]\] (Table [1](#Tab1){ref-type="table"}). In this group of proteins that have presented different abundance level (258\_*equi*:1002\_*ovis*), 49 proteins were more abundant and 71 less abundant (Table [1](#Tab1){ref-type="table"}). To visualize this differential distribution of the core-proteome a volcano plot of the log~2~ ratio of 258\_*equi*/1002\_*ovis* versus Log (e) Variance was generated (Fig. [2b](#Fig2){ref-type="fig"}). Interestingly, the Phospholipase D (Pld), the major virulence factor of *C. pseudotuberculosis*, was more abundant in 258\_*equi*, than in 1002\_*ovis* (Table [1](#Tab1){ref-type="table"}). The Pld have an important play role in the pathogenic process of *C. pseudotuberculosis*, due to the sphingomyelinase activity of the Pld, this exotoxin increases vascular permeability through the exchange of polar groups attached to membrane-bound lipids and helps the bacteria in spread inside the host \[[@CR34], [@CR35]\]. In addition, this exotoxin is able to reduce the viability of both macrophages and neutrophils \[[@CR34], [@CR36]\]. In comparative proteomic studies between 1002\_*ovis* and C231\_*ovis* exoproteome, Pld was detected only in the C231\_*ovis* supernatant \[[@CR13], [@CR15], [@CR16]\]. A study performed with pld mutant strains presented decreased virulence \[[@CR37]\]. Thus, in relation to 258\_*equi*, 1002\_*ovis* could present a low potential of virulence.Table 1Differentially regulated proteins between 258\_*equi* and 1002\_*ovis*AccessionDescription258:1002\
Log(2)Ratio^(a)^258\_*equi*1002\_*ovis*Score*p\_*value^(a)^Cellular processes and signaling Adhesion and motility cell  I3QUW8_CORPSD9Q5S4_CORP1Periplasmic zinc binding protein troA4245,52-1,320 Cell wall/Membrane and Envelope biogenesis  I3QYI6_CORPSD9Q3G9_CORP1Phospho N acetylmuramoyl pentapeptide166,051,221  I3QZH4_CORPSD9Q4F8_CORP1Corynomycolyl transferase3886,67-1,450  I3R044_CORPSD9Q526_CORP1Peptidoglycan recognition proteino5283,55−2,060D9Q4M0_CORP1Cell wall channel2220,85−2,140  I3QYK8_CORPSD9Q3J1_CORP1Cell wall peptidase NlpC P60 protein1207,7−2,780 Defense mechanism  I3QW82_CORPSD9Q743_CORP1Cold shock protein6171,91,371  I3R0B7_CORPSD9Q597_CORP1DNA protection during starvation protein70,504,73−1,480  I3QV66_CORPSD9Q632_CORP1Cold shock protein31,703,46−24580  I3QZX1_CORPSD9Q4V4_CORP1Protein GrpE57,665,59−2,640  I3QZW9_CORPSD9Q4V2_CORP1Heat shock protein HspR929,96−3,430 Intracellular trafficking secretion and vesicular transport  I3QVC7_CORPSD9Q697_CORP1ABC type transporter376,362,911  I3QZ34_CORPSD9Q431_CORP1ABC transporter ATP binding protein6339,111,541  I3QZQ5_CORPSD9Q4N9_CORP1ABC superfamily ATP binding cassette25,578,26−1,380  I3R0D8_CORPSD9Q5B9_CORP1Oligopeptide transport system permease705,01−1,450,01 Post-translational modification, protein turnover, chaperones  I3QWY7_CORPSD9Q7U6_CORP1Thioredoxin TrxA1832,123,151  I3QVC2_CORPSD9Q692_CORP1Thiol disulfide isomerase thioredoxin157,881,801  I3QXH3_CORPSD9Q8C5_CORP1Proteasome accessory factor PafA2305,06−1,320  I3QZA4_CORPSD9Q493_CORP1Glutaredoxin like protein nrdH3140,61−1,340  I3QUL7_CORPSD9Q5I3_CORP1Peptidyl prolyl cis trans isomerase49,161,11−1,440  I3QWQ3_CORPSD9Q7L6_CORP1Ferredoxin54,332,67−1,480  I3QW91_CORPSD9Q753_CORP1Peptidyl prolyl cis trans isomerase19,736,36−1,630  I3QV23_CORPSD9Q5Y2_CORP1Catalase52,016,22−1,700  I3QUX7_CORPSD9Q5T5_CORP1Glyoxalase Bleomycin resistance protein18,489,51−1,990  I3QVR1_CORPSD9Q6M3_CORP110 kDa chaperonin90,387,73−2,780 Signal transduction mechanisms  I3QY22_CORPSD9Q8W9_CORP1Phosphocarrier protein HPr38,569,08−2,920Information storage and processing DNA Metabolism: replication, recombination and repair  I3QV41_CORPSD9Q606_CORP1Metallophosphoesterase529,631,881  I3QWM2_CORPSExodeoxyribonuclease 7 small subunit10,725,45−2,000 Transcription: regulation, degradation and RNA processing  I3QX71_CORPSD9Q817_CORP1SAM dependent methyltransferase y397,161,250,96  I3QWD6_CORPSD9Q7A0_CORP1TetR family regulatory protein5685,08−1,380  I3QXS5_CORPSD9Q8M5_CORP1N utilization substance protein B homol16,977,04−1,420  I3QWH0_CORPSD9Q7D4_CORP1Transcriptional regulatory protein PvdS7456,32−1,480  I3QYU0_CORPSD9Q3T4_CORP1Ferric uptake regulatory protein7805,46−1,760  I3QWK3_CORPSD9Q7G7_CORP1Transcription elongation factor GreA77,246,3−1,870  I3QZJ2_CORPSD9Q4H4_CORP1Transcriptional regulator10,476,01−1,930  I3QUZ7_CORPSD9Q5V6_CORP1Nucleoid associated protein ybaB81,447,09−3,040  I3QUU4_CORPSD9Q5Q1_CORP1YaaA protein25,362,05−3,140Translation, ribosomal structure and biogenesis  I3R0I2_CORPSD9Q5F9_CORP1Ribosomal RNA small subunit methyltrans395,991,291  I3QWD9_CORPSD9Q7A3_CORP130S ribosomal protein S144756,75−1,470Metabolism Amino acid transport and metabolismD9Q3B4_CORP1Glutamate dehydrogenase1534,863,561  I3QXI1_CORPSD9Q8D2_CORP1Aspartate ammonia lyase2326,211,601  I3QWF9_CORPSD9Q7C4_CORP1Glycine betaine transporter136,231,211  I3QV21_CORPSD9Q5Y0_CORP1Aspartate semialdehyde dehydrogenase8778,47−1,280  I3QWZ5_CORPSD9Q7V4_CORP1Cysteine desulfurase1813,31−1,310  I3QXT1_CORPSD9Q8N1_CORP1Chorismate synthase5341,49−1,410  I3QXI5_CORPSD9Q8D5_CORP1Phosphoribosyl ATP pyrophosphatase25,184,13−1,900  I3QXL8_CORPSD9Q8G8_CORP1UPF0237 protein Cp258 109616,011,21−1,960  I3QZZ5_CORPSD9Q4X5_CORP1Urease subunit beta4349,97−2,120 Carbohydrate transport and metabolism  I3R0E6_CORPSD9Q5C6_CORP1Aldose 1 epimerase221,552,781  I3QV93_CORPSD9Q660_CORP1Formate acetyltransferase 19381,312,001  I3QZB7_CORPSD9Q4A5_CORP1Phosphoglucomutase359,431,771  I3QWW1_CORPSD9Q7S1_CORP1L lactate permease103,531,380,99D9Q8W7_CORP1PTS system fructose specific EIIABC191,711,351  I3QY20_CORPSD9Q8W6_CORP11 phosphofructokinase2879,521,321  I3R064_CORPSD9Q545_CORP1L lactate dehydrogenase5695,041,321  I3R051_CORPSD9Q691_CORP1Probable phosphoglycerate mutase2014,4−1,240D9Q396_CORP1PTS system fructose specific IIABC507,53−1,250  I3QWR8_CORPSD9Q7N1_CORP1Sucrose 6 phosphate hydrolase6075,08−1,340  I3QYN0_CORPSD9Q3L2_CORP1Glycine cleavage system H proteino91,529,52−1,380  I3QWH7_CORPSD9Q7D8_CORP1Glyceraldehyde 3 phosphate dehydrogenase9529,4−2,680 Coenzyme metabolismD9Q862_CORP1ATP dependent dethiobiotin synthetase B104,92−1,241  I3QUY1_CORPSD9Q5T9_CORP1Pyridoxal biosynthesis lyase PdxSo1029,15−1,420  I3QXF8_CORPSD9Q8B1_CORP1Precorrin 8X methyl mutase34,981,98−1,770  I3QXE1_CORPSD9Q893_CORP1Hemolysin related protein3609,761,350 Energy metabolism  I3QUS5_CORPSD9Q5N2_CORP1NADH dehydrogenase3257,663,141  I3QZ12_CORPSD9Q411_CORP1Malate dehydrogenase11,220,591,221  I3QXN4_CORPSD9Q8I5_CORP1Cytochrome oxidase assembly protein297,19−1,860,09  I3QYB6_CORPSD9Q3A4_CORP1Nitrogen regulatory protein P II16,165,93−2,290 Inorganic Ion Transport and Metabolism  I3R097_CORPSD9Q575_CORP1Cation transport protein882,31−4,641  I3QZG5_CORPSD9Q4F0_CORP1Trk system potassium uptake protein trk2973,221,251  I3QVU4_CORPSD9Q6Q3_CORP1Hemin binding periplasmic protein hmuT607,641,711  I3QVT3_CORPSD9Q6P2_CORP1Manganese ABC transporter substrate binding3917,51,510 Lipid transport and metabolism  I3QUM7_CORPSD9Q5J0_CORP1Phospholipase D25,847,673,271  I3QZM9_CORPSD9Q4L5_CORP1Secretory lipase12543,081 Nucleotide metabolism  I3QZR5_CORPSD9Q4P8_CORP1Purine phosphoribosyltransferase227,514,451  I3QZF7_CORPSD9Q4E2_CORP1Phosphoribosylformylglycinamidine synth978,571,451  I3QXV6_CORPSD9Q8Q6_CORP1Adenine phosphoribosyltransferaseo907,161,441  I3QZ07_CORPSD9Q406_CORP1Nucleoside diphosphate kinase14,996,331,351  I3QZG8_CORPSD9Q4F3_CORP1HIT family protein4039,811,211 Secondary metabolites biosynthesis, transport and catabolism  I3QWA4_CORPSD9Q766_CORP1Multidrug resistance protein norMo208,761,350,98Poorly characterized General function prediction only  I3QXE6_CORPSD9Q898_CORP1Methyltransferase type 11102,292,840,99  I3QWH3_CORPSD9Q7D6_CORP1Enoyl CoA hydratase225,92,141D9Q5M7_CORP1Unknown function2201,881,931  I3QZJ7_CORPSD9Q4I2_CORP1Carbonic anhydrase550,461,811  I3QWR6_CORPSD9Q7M9_CORP1Unknown function246,051,240,98  I3QX38_CORPSCutinase11,245,11−1,480  I3QXY3_CORPSD9Q8T2_CORP1Chlorite dismutase32,986,51−1,510  I3QW56_CORPSD9Q720_CORP1Methylmalonyl CoA carboxyltransferase 14283,03−1,520  I3QWE6_CORPSD9Q7B0_CORP1Serine protease5615,41−1,540  I3QX14_CORPSD9Q7X2_CORP1Aldo keto reductase6121,73−1,630  I3QWR9_CORPSD9Q7N2_CORP1Alpha acetolactate decarboxylase1839,59−1,730  I3QUU3_CORPSD9Q5Q0_CORP1UPF0145 protein Cp258 01013922,57−1,770  I3QV73_CORPSD9Q639_CORP1Hydrolase domain containing protein5759,37−2,230  I3QZM7_CORPSD9Q4L2_CORP1Rhodanese related sulfurtransferase7428,74−2,460  I3QYY9_CORPSD9Q3Y7_CORP1Ankyrin domain containing proteino11,948,84−2,840  I3QW24_CORPSD9Q6Y4_CORP1Hydrolase domain containing protein15,589,93−3,040 Unknown function  I3R0H3_CORPSD9Q5F1_CORP1Unknown function7862,733,591  I3QX01_CORPSD9Q7W0_CORP1Unknown function276,683,431  I3QYP3_CORPSD9Q3P0_CORP1Unknown function1609,292,841  I3QWZ8_CORPSD9Q7V7_CORP1Unknown function1476,562,581  I3R0H2_CORPSD9Q5F0_CORP1Unknown function572,191,901  I3QY71_CORPSD9Q919_CORP1Unknown function1466,61,781  I3QWL3_CORPSD9Q7H7_CORP1Unknown function304,961,650,98  I3QUW1_CORPSD9Q5R7_CORP1Unknown function504,131,601  I3QYF2_CORPSD9Q3D7_CORP1Unknown function985,971,471  I3QWR5_CORPSD9Q7M8_CORP1Unknown function103,031,451  I3QVG0_CORPSD9Q6C8_CORP1Unknown function4085,831,391  I3QXI8_CORPSD9Q8D8_CORP1Unknown function87,929,25−1,350  I3QVZ1_CORPSD9Q6U7_CORP1Unknown function64,404,7−1,380  I3R094_CORPSD9Q572_CORP1Unknown function4367,05−1,680  I3QYW4_CORPSD9Q3V8_CORP1Unknown function15,928,9−1,960  I3QUX9_CORPSD9Q5T7_CORP1Unknown function8100,51−2,000  I3QYG8_CORPSD9Q3F3_CORP1Unknown function78,035,52−2,090  I3QUZ5_CORPSD9Q5V4_CORP1Unknown function77,763,68−2,090  I3QUR3_CORPSD9Q5M1_CORP1Unknown function12,731,48−2,270  I3QVV7_CORPSD9Q6R6_CORP1Unknown function8564,11−3,470  I3QXX0_CORPSD9Q8S0_CORP1Unknown function19,485,3−3,500  I3QW02_CORPSD9Q6W1_CORP1Unknown function49,581,23−3,760  I3QVS0_CORPSD9Q6N1_CORP1Unknown function66,162,63−4,870  I3R0G5_CORPSD9Q5E4_CORP1Unknown function39,265,48−5,650

The 120 differential proteins were organized by cluster of orthologous groups, and when evaluated the different biological processes that comprise each category listed above, we observed that 19 process were differentials between 258\_*equi* and 1002\_*ovis* (Fig. [2c](#Fig2){ref-type="fig"}, Additional file [7](#MOESM7){ref-type="media"}: Figure S2 and Additional file [8](#MOESM8){ref-type="media"}: Figure S3). The majority of the more abundant proteins (258\_*equi*:1002\_*ovis*) are related to cellular metabolism. On other hand, the majority of the less abundant proteins (258\_*equi*:1002\_*ovis*) are classified as poorly characterized or of unknown function. However, when proteins of known or predicted function are evaluated the majority of the less abundant proteins are related to cellular processes and signaling.

Difference among the major functional classes identified from the core-proteome analysis of 1002\_*ovis* and 258\_*equi* {#Sec11}
------------------------------------------------------------------------------------------------------------------------

### Metabolism {#Sec12}

During the infection process, pathogens need to adjust their metabolism in response to nutrient availability inside and outside the host. In our proteomic study, we identified several proteins related to different metabolic pathways. To determine the metabolic network of each strain, the proteins identified in this study were analyzed using Kyoto Encyclopedia of Genes pathways and Genomes (KEGG) \[[@CR38]\]. A total of 321 and 320 proteins, corresponding to 1002\_*ovis* and 258\_*equi* respectively, were mapped onto different metabolic pathways (Additional file [9](#MOESM9){ref-type="media"}: Figure S4 and Additional file [10](#MOESM10){ref-type="media"}: Figure S5). We observed differences in the metabolism of the biovars, related to Amino acid transport and metabolism, Carbohydrate transport and metabolism, Coenzyme metabolism, Energy metabolism, Lipid transport and metabolism, Nucleotide metabolism and Secondary metabolites biosynthesis, transport and catabolism. Difference in the metabolism cellular, also already were observed in others comparative proteomic study of *C. pseudotuberculosis* \[[@CR13], [@CR16], [@CR17], [@CR19]\], as well as in the *Mycobacterium tuberculosis* pathogen \[[@CR39]\].

Interestingly, the PTS system fructose-specific EIIABC component (PstF) related to carbohydrate metabolism was more abundant in 258\_*equi*, than in 1002\_*ovis* (Table [1](#Tab1){ref-type="table"}). This protein showed increased abundance in field isolates of *C. pseudotuberculosis* biovar *ovis* grown in BHI when compared to C231\_*ovis*, a reference strain \[[@CR19]\]. This increased abundance of PstF in 258\_*equi*, suggests that this protein could be important to the transport of carbon source both biovar *ovis* and biovar *equi* strains. On the other hand, the Precorrin 8X methyl mutase involved in cobalamin and vitamin B12 synthesis can be required only in biovar *ovis* strains, this protein beside being more abundant in 1002\_*ovis* (Table [1](#Tab1){ref-type="table"}), was also detected with greater abundance in the field isolates of *C. pseudotuberculosis* biovar *ovis* after having been grown in BHI \[[@CR19]\]. Glutamate dehydrogenase (GDH) was detected more abundant in 258\_*equi* (Table [1](#Tab1){ref-type="table"}). A study performed with the *M. bovis* pathogen showed that GDH contributes to the survival of this pathogen during macrophage infection \[[@CR40]\].

In *C. pseudotuberculosis*, it was demonstrated that genes related the iron-acquisition are involved in the virulence of this pathogen \[[@CR41]\]. In the core-proteome of 1002\_*ovis* and 258\_*equi*, we detected proteins involved in this process, like CiuA, FagC and FagD; however, all these proteins were not differentially regulated between the two strains (Additional file [2](#MOESM2){ref-type="media"}: Table S1). On the other hand, HmuT protein, related to hemin uptake, was more abundant in 258\_*equi* (Table [1](#Tab1){ref-type="table"}). Additionally, we have also detected a cell surface hemin receptor in the exclusive proteome of this strain. Heme represents the major reservoir of iron source for many bacterial pathogens that rely on surface-associated heme-uptake receptors \[[@CR42]\]. The HmuT is a lipoprotein that acts as a hemin receptor. The *hmuT *gene is part of the operon *hmuTUV*, an ABC transport system (haemin transport system), which is normally present in pathogenic *Corynebacterium* \[[@CR43], [@CR44]\]. In addition, in the pathogen *C. ulcerans*, HmuT is required for normal hemin utilization \[[@CR44]\].

Information storage and processing {#Sec13}
----------------------------------

Of the total protein of proteins identify in the category "information storage and processing" the majority of the differential proteins were less abundant in 258\_*equi* (Table [1](#Tab1){ref-type="table"}). Only, Metallophosphoesterase involved in DNA repair, SAM dependent methyltransferase related to transcriptional process and Ribosomal RNA small subunit methyltransferase I involved in translation process were more induced in 258\_*equi*. In 1002\_*ovis* the Exodeoxyribonuclease 7 important protein related to the DNA-damage pathway was more induced in this strain. In addition, we identified the TetR family regulatory protein as more abundant in 1002\_*ovis*, this result was also observed in field isolates of *C. pseudotuberculosis* from sheep infected naturally \[[@CR19]\]. TerR proteins are related to regulation of multidrug efflux pumps, antibiotic biosynthesis, catabolic process and cellular differentiation process \[[@CR45]\]. Others important transcriptional regulators also were induced in 1002\_*ovis* such as PvdS and GreA regulators.

Cellular processes and signaling {#Sec14}
--------------------------------

Our proteomic analyses detected differentially regulated proteins belonging to different antioxidant systems. These could contribute to the survival of C. *pseudotuberculosis* in various stress conditions, such as reactive oxygen species (ROS) and reactive nitrogen species (RNS), which are generally found in macrophage. The three major thiol-dependent antioxidant systems in prokaryotic pathogens are the thioredoxin system (Trx), the glutathione system (GSH-system) and the catalase system \[[@CR46]\]. Thioredoxin TrxA and Thiol-disulfide isomerase thioredoxin were more abundant in 258\_*equi* (Table [1](#Tab1){ref-type="table"}). These proteins are involved in the Trx-system, which has a major role against oxidative stress \[[@CR46]\]. However, proteins like catalase and glutaredoxin (nrdH) were less abundant in 258\_*equi* (Table [1](#Tab1){ref-type="table"}), being more active in 1002\_*ovis*. Catalase plays an important role in resistance to ROS and RNS, as well as in the virulence of *M. tuberculosis* \[[@CR47]\]. The protein NrdH has a glutaredoxin amino acid sequence and thioredoxin activity. It is present in *Escherichia coli* \[[@CR48]\] and *C. ammoniagenes* \[[@CR49]\], as well as in bacteria where the GSH system is absent, such as *M. tuberculosis* \[[@CR50]\]. Thus, the presence of NrdH may represent one more factor that contributes to the resistance of *C. pseudotuberculosis* against ROS and RNS during the infection process, as well as to the maintenance of the balance of intracellular redox potential. Proteins like NorB and Glyoxalase/Bleomycin, which play roles in the nitrosative stress response of 1002\_*ovis*, were identified in the exclusive proteome of this strain (Additional file [3](#MOESM3){ref-type="media"}: Table S2) \[[@CR14], [@CR18]\]. These results shown that beside of present proteins with difference in abundance both strains present a set of proteins that could contribute to adaptive process under stress conditions.

Difference proteomic observed in the exclusive proteome of 258\_*equi* and 1002\_*ovis* {#Sec15}
---------------------------------------------------------------------------------------

We found respectively 105 and 96 proteins in the exclusive proteome of 1002\_*ovis* and 258\_*equi* (Fig. [1](#Fig1){ref-type="fig"}) (Additional file [3](#MOESM3){ref-type="media"}: Table S2 and Additional file [4](#MOESM4){ref-type="media"}: Table S3), related to different biological process (Additional file [7](#MOESM7){ref-type="media"}: Figure S2 and Additional file [8](#MOESM8){ref-type="media"}: Figure S3). Interestingly, in this exclusive proteome of 1002\_*ovis* and 258\_*equi*, we detected specific proteins in each strain (Table [2](#Tab2){ref-type="table"}, Additional file [3](#MOESM3){ref-type="media"}: Table S2 and Additional file [4](#MOESM4){ref-type="media"}: Table S3). In the exclusive proteome of 258\_*equi*, the ORFs that codify twenty proteins are annotated as pseudogene in 1002\_*ovis* (Table [2](#Tab2){ref-type="table"}, Additional file [3](#MOESM3){ref-type="media"}: Table S2 and Additional file [4](#MOESM4){ref-type="media"}: Table S3). On the other hand, the ORFs that encode six proteins were not detected in the genome of 1002\_*ovis*. These proteins are two CRISPR, MoeB, and three unknown function proteins. CRISPR is an important bacterial defense system against infections by viruses or plasmids, this immunity is obtained from the integration of short sequences of invasive DNA 'spacers' into the CRISPR loci \[[@CR51]\].Table 2Exclusive proteins identified in 258\_*equi* and 1002\_*ovis*LocusLocusDescriptionBiological Process1002\_*ovis*Cp1002_1457−DNA methylase^b^DNA Metabolism: replication, recombination and repairCp1002_1872Cp258_1887Collagen binding surface protein Cna^d^Adhesion and motility cellCp1002_1859Cp258_1875Sdr family related adhesin^d^Adhesion and motility cellCp1002_2025Cp258_2050Glycoside hydrolase 15 related protein^d^Carbohydrate transport and metabolismCp1002_0387Cp258_0396Neuraminidase Sialidase^d^Lipid transport and metabolismCp1002_0262Cp258_0266Ppx/GppA phosphatase family^d^General function prediction onlyCp1002_1151Cp258_1168Zinc metallopeptidase^d^General function prediction onlyCp1002_0077Cp258_0091Unknown function^d^Unknown function258\_*equi*Cp258_0374−MoeB protein^a^Coenzyme metabolismCp258_1675−CRISPR associated protein^a^DNA Metabolism: replication, recombination and repairCp258_0028−CRISPR-associated protein^a^DNA Metabolism: replication, recombination and repairCp258_0076−Unknown function^a^Unknown functionCp258_0585−Unknown function^a^Unknown functionCp258_0586−Unknown function^a^Unknown functionCp258_0896Cp1002_0888Acetolactate synthase^c^Amino acid transport and metabolismCp258_0465Cp1002_0455Cystathionine gamma synthase^c^Amino acid transport and metabolismCp258_0313Cp1002_0310Aminopeptidase G^c^Amino acid transport and metabolismCp258_0893Cp1002_0884Dihydroxy acid dehydratase^c^Amino acid transport and metabolismCp258_1223Cp1002_1203Inositol 1 monophosphatase^c^Carbohydrate transport and metabolismCp258_1360Cp1002_1337Unknown function^c^Coenzyme metabolismCp258_1909Cp1002_1892Aldehyde dehydrogenase^c^Energy metabolismCp258_0123Cp1002_0109ABC type metal ion transport system^c^Inorganic Ion Transport and MetabolismCp258_1854Cp1002_1838Disulfide bond formation protein DsbB^c^Post-translational modification, protein turnover, chaperonesCp258_0395Cp1002_0386Methionine aminopeptidase^c^Post-translational modification, protein turnover, chaperonesCp258_1923Cp1002_1906Oligopeptide binding protein oppA^c^Intracellular trafficking secretion and vesicular transportCp258_1549Cp1002_1541ABC transporter ATP binding protein^c^Intracellular trafficking secretion and vesicular transportCp258_1566Cp1002_1561ABC transporter^c^Intracellular trafficking secretion and vesicular transportCp258_0693Cp1002_0689Phosphatase YbjI^c^General function prediction onlyCp258_1503Cp1002_1497Alpha beta hydrolase^c^General function prediction onlyCp258_1265Cp1002_1243Unknown function^c^General function prediction onlyCp258_0169Cp1002_0157NADPH dependent nitro flavin reductase^c^General function prediction onlyCp258_1351Cp1002_1329Unknown function^c^Unknown functionCp258_1916Cp1002_1899Unknown function^c^Unknown functionCp258_2099Cp1002_2077Unknown function^c^Unknown function(^a^) Strain-specific protein, ORF detected only in the genome of 258*\_equi*(^b^)Strain-specific protein, ORF detected only in the genome of 1002*\_ovis*(^c^) *ORF* predicted like pseudogene in 1002\_*ovis*(^d^) *ORF* predicted like pseudogene in 258\_*equi*

The distinction between the biovar *ovis* and biovar *biovar equi strains* is based on a biochemical assay, where biovar ovis strains are negative for nitrate reduction, whereas biovar equi strains are positive \[[@CR52]\]. However, to date, there is no available information regarding the molecular basis underlying nitrate reduction in *C. pseudotuberculosis* biovar *equi*. MoeB is involved in the molybdenum cofactor (Moco) biosynthesis, which plays an important role in anaerobic respiration in bacteria and also are required to activation of nitrate reductase (NAR) \[[@CR53]\]. In the closely related pathogen *M. tuberculosis* several studies have showed the great importance of molybdenum cofactor in its virulence and pathogenic process, mainly macrophage intracellular environmental \[[@CR54]\]. Therefore, more studies are necessary to explore the true role of Moco both physiology and virulence of biovar *equi* strains. Other protein that also could contribute to resistance of 258\_*equi* macrophage is NADPH dependent nitro/flavin reductase (NfrA), a pseudogene in 1002\_*ovis*. In addition, studies performed in *Bacillus subtilis* showed that NfrA is involved in both oxidative stress \[[@CR55]\] and heat shock resistance \[[@CR56]\].

In 1002\_*ovis*, only the ORF that encodes a DNA methylase was not found in the 258\_*equi* genome (Table [2](#Tab2){ref-type="table"}, Additional file [3](#MOESM3){ref-type="media"}: Table S2 and Additional file [4](#MOESM4){ref-type="media"}: Table S3). In addition, the ORFs that codifies seven proteins identified in the exclusive proteome of the strain 1002\_*ovis* are annotated like pseudogene in 258\_*equi* (Table [2](#Tab2){ref-type="table"}, Additional file [3](#MOESM3){ref-type="media"}: Table S2 and Additional file [4](#MOESM4){ref-type="media"}: Table S3). Inside this group, we have identified important proteins involved in the process of adhesion and invasion cellular, which might contribute in the pathogenesis of 1002\_*ovis*. Adhesion to host cells is a crucial step that favors the bacterial colonization; this process is mediated by different adhesins \[[@CR57]\]. We identified proteins such as: collagen binding surface protein Cna-like and Sdr family related adhesin, which are members of the collagen-binding microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) (Table [2](#Tab2){ref-type="table"}). This class of proteins is present in several Gram positive pathogens and plays an important role in bacterial virulence by acting mainly in the cellular adhesion process \[[@CR58]--[@CR61]\].

Another detected protein that might contribute to the virulence of 1002\_*ovis* is Neuraminidase (NanH) (Table [2](#Tab2){ref-type="table"}). This protein belongs to a class of glycosyl hydrolases that contributes to the recognition of sialic acids exposed on host cell surfaces \[[@CR62]\]. In *C. diphtheriae*, it was demonstrated that a protein with trans-sialidase activity promotes cellular invasion \[[@CR63], [@CR64]\]. In addition, NanH was reported to be immunoreactive in the immunoproteome of 1002\_*ovis*, showing the antigenicity of this protein \[[@CR65]\]. Interestingly, genomic difference in relation to gene involved in the adhesion and invasion process, also already were observed between biovar *ovis* strain and biovar *equi* strains, mainly in genes related to pilus \[[@CR10], [@CR12]\]. According to pathogenic process of each biovar, unlike biovar *equi* strain*s*, which rarely causes visceral lesions \[[@CR4]\], biovar *ovis* strains, are responsible mainly by visceral lesions \[[@CR2], [@CR35]\], what requires a high ability to adhere and invade the host cell, thus these protein could be responsible by this ability of biovar *ovis* strain in attacks visceral organs.

Proteogenomic analysis {#Sec16}
----------------------

In our proteomic analysis, the measured MS/MS spectra from the proteomic datasets of 1002\_*ovis* and 258\_*equi* were searched against a concatenated database composed by genome annotation of 1002\_*ovis* CP001809.2 version and 258\_*equi* CP003540.2 version for identify possible errors or unannotated genes. Thus, by adopting more stringent criteria of considering only proteins with a minimum representative of two peptides and a FDR \< 1%, we identified five proteins in 1002\_*ovis* and seven proteins in 258\_*equi*, which were not previously annotated. All parameters, as well as, the peptides sequence which were used for identification of these proteins are shown in Additional file [11](#MOESM11){ref-type="media"}: Table S6 and Additional file [12](#MOESM12){ref-type="media"}: Table S7. The proteins identified in this proteogenomic analysis are associated to different biological processes. For instance, the Aminopeptidase N involved in the amino acid metabolism was detected in 1002\_*ovis*, whereas the Cobaltochelatase (cobN), associated to cobalt metabolism, glutamate dehydrogenase (gdh) involved in the L-glutamate metabolism, the PTS system fructose specific EIIABC related to fructose metabolism and the Phosphoribosylglycinamide formyltransferase involved in the purine biosynthesis were all detected in 258\_*equi*. Proteins involved in DNA processes, such as Uracil DNA glycosylase in 258\_*equi*; and Exodeoxyribonuclease 7 small subunit in 1002\_*ovis* were also detected in both strains. Proteins with general function prediction only and unknown function were also identified in both strains.

Conclusion {#Sec17}
==========

In conclusion, we used a label-free quantitative approach to compare, for the first time, the proteome of *C. pseudotuberculosis* strains belonging to both *ovis* and *equi* biovars. Taken together, the findings reported here show a set of shared and exclusive factors of 1002\_*ovis* and 258\_*equi* at the protein level, which can contribute to understanding both the physiology and the virulence of these strains. In addition, the functional analysis of the genome of 1002\_*ovis* and 258\_*equi* allows the in silico validation of data of the genome of these strains. Thus, the proteins identified here may be used as potential new targets for the development of vaccines against *ovis* and *equi C. pseudotuberculosis* in future investigations.

Availability of supporting data {#Sec18}
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Additional file 1: Figure S1.Growth rates in BHI media of 1002\_*ovis* (blue circles) and 258\_*equi* (red triangles). (JPEG 278 kb) Additional file 2: Table S1.Total list of proteins identified in the core-proteome of 1002\_*ovis* and 258\_*equi*. (XLSX 215 kb) Additional file 3: Table S2.Total list of proteins identified in the exclusive proteome of 1002\_*ovis*. (XLSX 20 kb) Additional file 4: Table S3.Total list of proteins identified in the exclusive proteome of 258\_*equi*. (XLSX 21 kb) Additional file 5: Table S4.Total list of peptide and proteins identified 1002\_*ovis*. (XLSB 31769 kb) Additional file 6: Table S5.Total list of peptide and proteins identified 258\_*equi. (XLSB 33204 kb)* Additional file 7: Figure S2.The protein-protein interaction network of 1002\_*ovis*. (A) General interactome of differentially regulated proteins, identified in the exclusive proteome of 1002\_*ovis*. The proteins are marked with different shapes: exclusive proteome, circle; more abundant, square; less abundant, rhombus. The biological processes were marked with different colors: amino acid transport and metabolism, yellow; secondary metabolites biosynthesis, transport and catabolism, aquamarine; inorganic ion transport and metabolism, orange; coenzyme metabolism, brown; carbohydrate transport and metabolism, chartreuse green; nucleotide metabolism, cerulean; energy metabolism, olive; lipid transport and metabolism, viridian; adhesion and motility cell, crimson; iuntracellular trafficking secretion and vesicular transport, persian blue; signal transduction mechanisms, maroon; cell wall/membrane and envelope, gray; defense mechanism, red; post-translational modification, protein turnover, chaperones, electric blue; DNA metabolism, replication, recombination and repair, violet; translation, ribosomal structure and biogenesis, amber; transcription, regulation, degradation and RNA processing, salmon; poorly characterized, white. (JPEG 3310 kb) Additional file 8: Figure S3.The protein-protein interaction network of 258\_*equi*. (A) General interactome of the differentially regulated proteins, identified in the exclusive proteome of 258\_*equi*. The proteins are marked with different shapes: exclusive proteome, circle; more abundant, square; less abundant, rhombus. The biological processes are marked with different colors: amino acid transport and metabolism, yellow; secondary metabolites biosynthesis, transport and catabolism, aquamarine; inorganic ion transport and metabolism, orange; coenzyme metabolism, brown; carbohydrate transport and metabolism, chartreuse green; nucleotide metabolism, cerulean; energy metabolism, olive; lipid transport and metabolism, viridian; adhesion and motility cell, crimson; intracellular trafficking secretion and vesicular transport, persian blue; signal transduction mechanisms, maroon; cell wall/membrane and envelope, gray; defense mechanism, red; post-translational modification, protein turnover, chaperones, electric blue; DNA metabolism, replication, recombination and repair, violet; translation, ribosomal structure and biogenesis, amber; transcription, regulation, degradation and RNA processing, salmon; poorly characterized, white. (JPEG 4178 kb) Additional file 9: Figure S4.Metabolic network of 1002\_*ovis*. Red line, proteins identified in the proteomic analysis, other colors represent proteins not identified in this study. (JPEG 8633 kb) Additional file 10: Figure S5.Metabolic network of 258\_*equi*. Red line, proteins identified in the proteomic analysis, other colors represent proteins not identified in this study. (JPEG 1267 kb) Additional file 11: Table S6.Proteins identified in 1002\_*ovis* by Proteogenomics. (XLSX 216 kb) Additional file 12: Table S7.Proteins identified in 258\_*equi* by Proteogenomics. (XLSX 266 kb)
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